.jpg)
1 hour ago
3
Article content
Event will feature detailed overviews of two innovative contact lens technologies with potential to redefine the standard of care
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the second event in its R&D “Teach-in” webinar series that provides deeper insights on the company’s robust and differentiated product pipeline.
Article content
Article content
On Monday, June 1, 2026, at 1:00 p.m. ET, Executive Vice President of Research & Development and Chief Medical Officer Yehia Hashad, MD, will be joined by members of his leadership team to discuss two promising contact lens assets currently under development:
Article content
Article content
- First-of-its-kind bioactive contact lens would be the first new contact lens material in over 25 years – designed with polymerized hyaluronic acid to provide all-day comfort, hydration and lubrication
- Cutting-edge silicone hydrogel daily contact lens featuring premium material and advanced design to help slow the progression of myopia
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Chairman and CEO Brent Saunders and Executive Vice President and Chief Financial Officer Sam Eldessouky will also participate.
Article content
Registration for the live webinar hosted by Citi as part of its Head, Shoulders, Knees, and Toes series can be accessed here. Following the event, a replay will be available on the Investor Relations page of the Bausch + Lomb website.
Article content
About Bausch + Lomb
Article content
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at
Article content
Article content
and connect with us on
Article content
Article content
,
Article content
Article content
,
Article content
Article content
,
Article content
Article content
and
Article content
Article content
.
Article content
© 2026 Bausch + Lomb.
Article content
Article content
Article content
Article content
View source version on businesswire.com:
Article content
Article content
Article content
Contacts
Article content
Media Contact:
Article content
Article content
Chris Clark
Article content
Article content
Article content
Article content
(848) 360-1100
Article content
Investor Contact:
Article content
Article content
George Gadkowski
Article content
Article content
Article content
Article content
(877) 354-3705 (toll free)
Article content
English (US)